Drug Shortage Report for IVOZFO
| Report ID | 210486 |
| Drug Identification Number | 02488086 |
| Brand name | IVOZFO |
| Common or Proper name | fosfomycin (supplied as fosfomycin sodium) |
| Company Name | VERITY PHARMACEUTICALS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | FOSFOMYCIN |
| Strength(s) | 4G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 4 g vial |
| ATC code | J01XX |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-01-31 |
| Actual start date | |
| Estimated end date | 2024-05-30 |
| Actual end date | 2024-05-28 |
| Shortage status | Resolved |
| Updated date | 2024-06-22 |
| Company comments | Implementation of improved testing |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2560 MATHESON BLVD. E., SUITE 220 MISSISSAUGA, ONTARIO CANADA L4W 4Y9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-06-22 | French | Compare |
| v5 | 2024-06-22 | English | Compare |
| v4 | 2024-02-01 | English | Compare |
| v3 | 2023-11-17 | French | Compare |
| v2 | 2023-11-17 | English | Compare |
| v1 | 2023-11-17 | English | Compare |
Showing 1 to 6 of 6